<![CDATA[ AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS)]]>https://aidsinfo.nih.gov/e-news/archive60<![CDATA[HHS Guidance on Caring for Persons with HIV in Disaster Areas Updated]]>https://aidsinfo.nih.gov/e-news/archive/2018/9/18The HHS Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Who Have Been Displaced by Disasters (such as a Hurricane) has been updated. The guidance is intended for health care providers attending to the medical needs of adults and children with HIV who have been displaced from disaster areas and who have not yet secured HIV care in the areas where they have relocated.

Visit AIDSinfo to view or download the full guidance.

 

]]>
Tue, 18 Sep 2018 00:00:00 GMT
<![CDATA[ Explore AIDSinfo’s HIV Drug Information Resources]]>https://aidsinfo.nih.gov/e-news/archive/2018/9/18Did you know that AIDSinfo has more than 150 fact sheets on HIV-related medications? The AIDSinfo Drug Database includes information on Food and Drug Administration (FDA)-approved antiretroviral (ARV) and HIV-related opportunistic infection (OI) drugs, as well as information on investigational HIV drugs and vaccines that are currently being studied in clinical trials.

The FDA-approved ARV and OI drug fact sheets are written in plain language and include information useful for people taking the drug. Along with the fact sheets, people can view the FDA drug labels directly on the AIDSinfo website.

The investigational drug fact sheets are available in two formats: a plain language version, which includes an overview of the drug and information on clinical trials studying the drug; and a health professional version, which includes detailed, scientific information about the drug, including information on the pharmacology of the drug and on adverse events of the drug identified in clinical trials.

Do you want to learn more about HIV-related medications? Search the AIDSinfo Drug Database to find information on an HIV-related drug of interest. Also, check out the AIDSinfo HIV Treatment: The Basics and FDA-Approved HIV Medicines fact sheets.

 

]]>
Tue, 18 Sep 2018 00:00:00 GMT
<![CDATA[ September 27 is National Gay Men’s HIV/AIDS Awareness Day]]>https://aidsinfo.nih.gov/e-news/archive/2018/9/18Centers for Disease Control and Prevention (CDC), in 2014, gay and bisexual men made up an estimated 2% of the U.S. population but accounted for 70% of new HIV infections.

September 27 is a day set aside each year to focus on the impact of HIV and AIDS on gay and bisexual men. To learn more, visit the AIDSinfo National Gay Men’s HIV/AIDS Awareness Day webpage [en español].]]>
Tue, 18 Sep 2018 00:00:00 GMT
<![CDATA[AIDSinfo Releases Fact Sheets on Two New HIV Medications]]>https://aidsinfo.nih.gov/e-news/archive/2018/9/6
  • Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate)
  • Pifeltro (doravirine)
  • Delstrigo, a fixed-dose combination tablet, is a complete regimen for the treatment of HIV infection and should not be used with other HIV medicines. Pifeltro is always used in combination with other HIV medicines.

    Do you want to learn more about HIV medicines? Search the AIDSinfo Drug Database and view the FDA-Approved HIV Medicines fact sheet.

     

    ]]>
    Thu, 6 Sep 2018 00:00:00 GMT
    <![CDATA[ September 18 is National HIV/AIDS and Aging Awareness Day]]>https://aidsinfo.nih.gov/e-news/archive/2018/9/6According to the Centers for Disease Control and Prevention (CDC), in 2014, an estimated 45% of Americans living with diagnosed HIV were aged 50 and older. September 18 is National HIV/AIDS and Aging Awareness Day—a day to call attention to the challenges of HIV prevention, testing, treatment, and care that older Americans face. For example, although HIV risk factors are similar for all adults, older adults may be less aware of these factors and the importance of testing to detect HIV in its earliest stages. To learn more, visit the AIDSinfo National HIV/AIDS and Aging Awareness Day webpage [en español].

     

    ]]>
    Thu, 6 Sep 2018 00:00:00 GMT
    <![CDATA[ Recent HIV News from NIAID]]>https://aidsinfo.nih.gov/e-news/archive/2018/9/6
  • August 28, 2018: HIV/AIDS Research Yields Dividends Across Medical Fields
  • August 30, 2018: Novel Intervention Halves Rate of Death Among People Living with HIV Who Inject Drugs
  • ]]>
    Thu, 6 Sep 2018 00:00:00 GMT
    <![CDATA[AIDSinfo Infographics Offer a Visual Guide to Understanding HIV]]>https://aidsinfo.nih.gov/e-news/archive/2018/8/23AIDSinfo educational materials include infographics in English and Spanish. The infographics provide a visual guide to understanding HIV-related concepts, such as the HIV life cycle, drug resistance, and how to prevent mother-to-child transmission of HIV. The infographics are intended for anyone interested in HIV, including health care providers seeking easy-to-understand information for their patients.

    Browse the entire set of infographics on the AIDSinfo Infographics page or use the filters to view them by topic—HIV Overview, HIV Treatment, Living with HIV, and HIV Prevention. Visit infoSIDA to view the infographics in Spanish.

     

    ]]>
    Thu, 23 Aug 2018 00:00:00 GMT
    <![CDATA[ Recent HIV News from NIAID]]>https://aidsinfo.nih.gov/e-news/archive/2018/8/23
  • August 13, 2018: During HIV Infection, Antibody Can Block B Cells from Fighting Pathogens
  • August 20, 2018: NIH Officials: Closing Treatment Gaps Critical to Ending the U.S. HIV Epidemic
  • ]]>
    Thu, 23 Aug 2018 00:00:00 GMT
    <![CDATA[Updated AIDSinfo Consumer Fact Sheets Offer an Overview of HIV]]>https://aidsinfo.nih.gov/e-news/archive/2018/8/9The updated AIDSinfo consumer fact sheets provide an introduction to HIV, including the basics of HIV testing, treatment, and research. Each fact sheet includes a summary of key points and links to additional information and resources.


    View the updated fact sheets:

    Visit infoSIDA to view the fact sheets in Spanish.

    ]]>
    Thu, 9 Aug 2018 00:00:00 GMT